Lingfeng Zeng

596 total citations
23 papers, 450 citations indexed

About

Lingfeng Zeng is a scholar working on Molecular Biology, Nephrology and Surgery. According to data from OpenAlex, Lingfeng Zeng has authored 23 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Surgery. Recurrent topics in Lingfeng Zeng's work include Chronic Kidney Disease and Diabetes (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Mitochondrial Function and Pathology (4 papers). Lingfeng Zeng is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Renal Diseases and Glomerulopathies (5 papers) and Mitochondrial Function and Pathology (4 papers). Lingfeng Zeng collaborates with scholars based in China, Hong Kong and France. Lingfeng Zeng's co-authors include Lin Sun, Ying Xiao, Ming Yang, Cheuk‐Chun Szeto, Chenrui Li, Yachun Han, Shan Xiong, Na Jiang, Ling Wei and Li Li and has published in prestigious journals such as The FASEB Journal, European Heart Journal and Journal of Hepatology.

In The Last Decade

Lingfeng Zeng

21 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfeng Zeng China 10 211 149 80 66 65 23 450
Xing Mao China 11 171 0.8× 159 1.1× 67 0.8× 51 0.8× 37 0.6× 18 446
Jinfei Yang China 13 206 1.0× 105 0.7× 109 1.4× 38 0.6× 39 0.6× 26 462
Yunxia Du China 13 365 1.7× 122 0.8× 74 0.9× 57 0.9× 49 0.8× 30 601
Himanshu Sankrityayan India 14 130 0.6× 121 0.8× 38 0.5× 45 0.7× 32 0.5× 20 410
Suxia Yang China 16 280 1.3× 118 0.8× 51 0.6× 103 1.6× 38 0.6× 27 580
Baoping Chen China 10 262 1.2× 84 0.6× 49 0.6× 79 1.2× 36 0.6× 19 469
Qiaoyan Guo China 12 195 0.9× 185 1.2× 46 0.6× 36 0.5× 37 0.6× 33 495
Jia Guo China 14 233 1.1× 115 0.8× 71 0.9× 123 1.9× 23 0.4× 38 591
Ajinath Kale India 14 103 0.5× 153 1.0× 51 0.6× 22 0.3× 35 0.5× 26 359
Wangqiu Gong China 12 366 1.7× 120 0.8× 93 1.2× 197 3.0× 32 0.5× 15 607

Countries citing papers authored by Lingfeng Zeng

Since Specialization
Citations

This map shows the geographic impact of Lingfeng Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Zeng more than expected).

Fields of papers citing papers by Lingfeng Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Zeng. The network helps show where Lingfeng Zeng may publish in the future.

Co-authorship network of co-authors of Lingfeng Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng Zeng. A scholar is included among the top collaborators of Lingfeng Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng Zeng. Lingfeng Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Guanghui, et al.. (2025). Research progress of Sinomenium in the treatment of rheumatoid arthritis and suggestions for future research. Allergologia et Immunopathologia. 53(SP1). 1–10.
2.
Lin, Huapeng, Terry Cheuk‐Fung Yip, Hye Won Lee, et al.. (2024). AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatment. Journal of Hepatology. 82(3). 456–463. 5 indexed citations
3.
Zeng, Lingfeng, Jack Kit‐Chung Ng, Winston Wing‐Shing Fung, et al.. (2024). Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease. BMC Nephrology. 25(1). 32–32. 5 indexed citations
4.
Zeng, Lingfeng, Gordon Chun‐Kau Chan, Jack Kit‐Chung Ng, et al.. (2023). The effect of Dipeptidyl peptidase 4 (DPP-4) inhibitors on hemoglobin level in diabetic kidney disease: A retrospective cohort study. Medicine. 102(32). e34538–e34538. 1 indexed citations
5.
Zeng, Lingfeng, Jack Kit‐Chung Ng, Winston Wing‐Shing Fung, et al.. (2023). Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease. Kidney & Blood Pressure Research. 48(1). 241–248. 4 indexed citations
6.
7.
Zeng, Lingfeng, Winston Wing‐Shing Fung, Gordon Chun‐Kau Chan, et al.. (2022). Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study. Kidney Medicine. 5(1). 100569–100569. 12 indexed citations
8.
9.
Lin, Huapeng, Lingfeng Zeng, Jing Yang, Wei Hu, & Ying Zhu. (2021). A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma. Frontiers in Oncology. 11. 608260–608260. 8 indexed citations
10.
Zeng, Lingfeng & Cheuk‐Chun Szeto. (2021). Urinary podocyte markers in kidney diseases. Clinica Chimica Acta. 523. 315–324. 24 indexed citations
11.
Yang, Ming, Chenrui Li, Shikun Yang, et al.. (2020). Mitophagy: A Novel Therapeutic Target for Treating DN. Current Medicinal Chemistry. 28(14). 2717–2728. 21 indexed citations
12.
Yang, Jinfei, Ying Xiao, Ling Wei, et al.. (2020). The single nucleotide polymorphism rs11643718 in SLC12A3 is associated with the development of diabetic kidney disease in Chinese people with type 2 diabetes. Diabetic Medicine. 37(11). 1879–1889. 9 indexed citations
13.
Li, Chenrui, Li Li, Ming Yang, Lingfeng Zeng, & Lin Sun. (2020). PACS-2: A key regulator of mitochondria-associated membranes (MAMs). Pharmacological Research. 160. 105080–105080. 62 indexed citations
14.
Jiang, Na, Hao Zhao, Yachun Han, et al.. (2020). HIF‐1α ameliorates tubular injury in diabetic nephropathy via HO‐1–mediated control of mitochondrial dynamics. Cell Proliferation. 53(11). e12909–e12909. 109 indexed citations
15.
Yang, Shikun, Lingfeng Zeng, Aimei Li, et al.. (2020). Comparison of 99mTc-DTPA and serum creatinine, cystatin C in detection of glomerular filtration rate: a retrospective clinical data analysis of 744 Chinese subjects. Nuclear Medicine Communications. 41(3). 219–227. 2 indexed citations
16.
Zhao, Hao, Na Jiang, Yachun Han, et al.. (2020). Aristolochic acid induces renal fibrosis by arresting proximal tubular cells in G2/M phase mediated by HIF‐1α. The FASEB Journal. 34(9). 12599–12614. 22 indexed citations
17.
Zeng, Lingfeng, Ying Xiao, & Lin Sun. (2019). A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy. Advances in experimental medicine and biology. 1165. 49–79. 100 indexed citations
18.
Yang, Shikun, Aimei Li, Yachun Han, et al.. (2019). Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice. Oxidative Medicine and Cellular Longevity. 2019. 1–13. 43 indexed citations
19.
Zeng, Lingfeng, et al.. (2015). Small Heat Shock Proteins and the Endoplasmic Reticulum: Potential Attractive Therapeutic Targets?. Current Molecular Medicine. 15(1). 38–46. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xing Mao Breakdown of academic impact, for papers by Jinfei Yang Breakdown of academic impact, for papers by Yunxia Du Breakdown of academic impact, for papers by Himanshu Sankrityayan Breakdown of academic impact, for papers by Suxia Yang Breakdown of academic impact, for papers by Baoping Chen Breakdown of academic impact, for papers by Qiaoyan Guo Breakdown of academic impact, for papers by Jia Guo Breakdown of academic impact, for papers by Ajinath Kale Breakdown of academic impact, for papers by Wangqiu Gong
Rankless by CCL
2026